OOGI, MCET, CLRH, INCCE, CDXC, DNRR, AMEL, CCTR, ZVTK

I just can’t help myself!

There are so many penny stock plays that I could share with you that it is hard to limit it to these 9.   Some are the “usual suspects” i.e. ones that you see all the time (ZVTK, CCTR, AMEL) and others are new to me.

These are all penny and sub-penny stocks that are in play for reasons of news, volume or price.  Each one represents an opportunity to make money on the long or short side.  Let’s see which one works for you my readers.

Odyssey Oil & Energy Inc. (OTC: OOGI) is up 56.67% to $0.235 following the announcement of a strategic partnership with Hylem Water Ltd. The company will help Hylem raise $2.5 million in order to implement its business plan, and will take a 51% stake in the firm as a result of the transaction.  (OTC:OOGI), ($OOGI)

Great short candidate, although the stock has already fallen from its high of 30 cents intraday.  I have reviewed the PR’s and financials and there isn’t much there.  The company is still development stage in all aspects and doesn’t appear to be too close to revenues.

Still, the company does have some good prospects.  The challenge for a company like this is to stay focused enough to make at least one of their “businesses” succeed”

MultiCell Technologies Inc. (OTC: MCET) is up 38.89% to $0.0125 following the report that it was granted a European patent covering certain of its therapeutic candidates for the treatment of cancer. (OTC:MCET), ($MCET)

The granting of the European patent is big news for MCET and the market responded accordingly.  The question is with this one-day pop what will the follow up be.  The stock vaulted to $0.0178 intraday before falling back to $.014.

A big gap at open, but the potential gain was still almost 50% for the day.  I am not too impressed with MCET yet….it has several U.S. patents and it is yet to effectively commercialize them.  The Euro patents are great, but I would like to see MCET generate significant revenues before I got too excited.

Clear-Lite Holdings Inc. (OTC: CLRH) is up 46.94% to $0.360.  The company has said that it will be expanding into new lines of environmentally-friendly businesses that will provide additional revenue opportunities outside of its cutting-edge, eco-friendly lighting products.  (OTC:CLRH), ($CLRH)

International Consolidated Companies Inc. (OTC: INCCE) is up 46.15% to $0.0095 on above-average volume.  (OTC:INCCE)(OTC:INCCE)

ChromaDex Corp. (OTC: CDXC) is up 15.20% to $1.44.  The company has said that it received an investment from The Frost Group LLC, which would allow the company to pursue clinical studies and commercialization of its new pTeroPure™ pterostilbene.  (OTC:CDXC), ($CDXC)

This is one company that might be worth keeping track of.   It is already $1.44 and much of the recent good news appears burnt into the stock price.

However, their nutritional extract, pterostilbene, has enormous potential based upon what I have read and the fact that the Frost Group is “ponying up” an undisclosed amount of money.   It is being touted as the next generation “Resveratrol”.  Also, the fact that it is a nutraceutical means that approval will happen much faster than if it was a pharmaceutical.

Denarii Resources Inc. (OTC: DNRR) is up 16.67% to $0.0420.  The company has provided an update on its Chile Coal recovery project. (OTC:DNRR), ($DNRR)

Amerilithium Corp. (OTC: AMEL) is up 21.74% to $1.68 on above-average volume.  (OTC:AMEL). ($AMEL)

China Crescent Enterprises Inc. (OTC: CCTR) is down 3.24% to $0.0209.  The company has scheduled an on-demand management update Web cast for release tomorrow, April 27th.  (OTC:CCTR), ($CCTR)

Zevotek Inc. (OTC: ZVTK) is up 3.39% to $0.0061.  (OTC:ZVTK), ($ZVTK)

Don’t forget to sign up for my periodic trading alerts.  I have an awesome track record of penny stock and small cap picks that I hope you can benefit from.  Go to my signup page to sign up for my Investor Soup alerts.

Good luck and good trading,

Jeffrey Dean

Editor

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.